Dovato 50-300 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F7CV2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,171
Award facts
- Contract value 100% obligated
- $11,171.41 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order awards $11.2K to AmerisourceBergen Drug Corp for the supply of Dovato 50-300 mg tablets (30-count units) under a firm fixed-price contract with the Defense Logistics Agency (DLA). The contract, issued on January 29, 2026, with an ultimate completion date of January 30, 2026, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with its parent company being Cencora, Inc. (doing business as AmerisourceBergen). This delivery order is executed under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.9M through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
Dovato is an antiretroviral medication used in HIV treatment, reflecting the DLA's critical role in supplying essential medications to military treatment facilities and veteran healthcare programs. AmerisourceBergen's position as a major federal pharmaceutical distributor is evidenced by its extensive portfolio of delivery orders spanning multiple therapeutic domains, including specialty medications, vaccines, and medical supplies. The company's non-set-aside competitive awards and firm fixed-price structure demonstrate its capability to meet federal procurement requirements in open competition, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible and comprehensive contract vehicles.
Quick answers
Who was awarded contract SPE2DR26F7CV2?
SPE2DR26F7CV2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26F7CV2 worth?
The government has obligated $11,171 on SPE2DR26F7CV2.
Is contract SPE2DR26F7CV2 an order under another contract?
Yes. SPE2DR26F7CV2 is a delivery order under SPE2DR25D3504, an indefinite delivery contract.
Was contract SPE2DR26F7CV2 competed?
The extent of competition for SPE2DR26F7CV2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award